The administration of JQ1, a potent inhibitor of BET bromodomain proteins resulted in reduced cell proliferation and markedly enhanced apoptosis in in vitro models of MYC-amplified medulloblastomas and prolonged survival in xenograft models [174]. The gene discussed is MYC; the disease is medulloblastoma.